FEATURED ARTICLES

• Innovative FSP Solutions For Biopharma Growth And Transition

  To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.

• Harnessing RWE For Effective External Control Arms In Clinical Trials

  Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.

• What To Look For In An Oncology CRO

  Learn seven of the critical factors for choosing an oncology-focused CRO that enable sponsors to identify partners aligning with their clinical research objectives.

• Advancing Neuroscience Research With Data-Driven Innovations And AI

  Learn how to employ data-driven insights, artificial intelligence, and decentralized clinical trials to accelerate drug development and address the intricate challenges of neuroscience research.

• Advancing Dermatology Drug Development: Key Takeaways From AAD 2025

  The 2025 American Academy of Dermatology (AAD) Annual Meeting underscored pivotal advancements in dermatology drug development, highlighting the essential role of innovative dermatology CROs.

• Navigating The Evolving Landscape Of Immunotherapy in Oncology

  Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.

• Pioneering Gene Therapy In Rare Diseases

  Overcoming barriers to gene therapy development requires continued innovation in manufacturing processes, harmonized regulatory approaches, and outcome-based pricing models.

• Evolution Of Clinical Trials In Europe

  The CTR and CTIS represent a paradigm shift in European clinical research, fostering a more efficient and transparent trial environment.

• The Future Of Good Clinical Practice: The ICH E6(R3) Update

  The release of the ICH E6(R3) Good Clinical Practice guideline in January 2025 marks a shift in clinical research, with significant implications for CROs, trial design, and quality management. 

• The Power Of Immunotherapy And Precision Medicine In Cancer Research

  Learn about the key criteria that sponsors should evaluate when selecting a partner for your IO trials to help them improve efficiency, and accelerate the development of life-saving cancer treatments.

• The Role Of Technology In Transforming Dermatology Clinical Trials

  AI and data-driven innovations are transforming dermatology clinical trials by enhancing efficiency, data accuracy, and patient access.

• Epidermolysis Bullosa: Future Perspectives In Drug Development

  Recent breakthroughs are signaling a promising shift in the landscape of Epidermolysis bullosa (EB) care from focusing on pain management to a growing commitment to curative strategies.

• Gene Therapy In Neurology: The Case For Optimism

  Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.

• Maximizing Efficiency: A Comprehensive Guide To Study Coordination Services

  Explore the critical role of study coordinators, emphasizing their expertise, strategic contributions, and the value they add to clinical research.

• Streamlining Early-Phase Oncology Study Start-Up In Today's Clinical Environment

  Explore the significance of targeted therapies and adaptive trial designs that prioritize patient-specific characteristics.

• Debunking Myths And Uncovering The Truths About Quality

  Explore this discussion about the myths and misconceptions surrounding quality and compliance.

• Precision Medicine: A New Era For Neurological Breakthroughs

  The growing potential of precision medicine is offering an effective way to address challenges that arise across the landscape of neurological care.

• Advancing Gene Therapy For Rare Diseases: Charting The Path To Transformative Treatments

  Delve into key considerations when conducting clinical trials for gene therapies, including collaboration between stakeholders, site management, regulatory compliance, and patient-centric strategies.